Although absent in normal epithelial cells, vimentin expression is upregulated during oncogenic transformation [44] and is considered a hallmark of the epithelial–mesenchymal transition (EMT) in motile epithelial cells during embryonic development and in metastatic cancer cells [45]. The gene discussed is VIM; the disease is metastatic malignant neoplasm.